FDA Approved: RECORLEV — Supplemental Application (Xeris Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for RECORLEV (levoketoconazole) submitted by Xeris Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• RECORLEV (Levoketoconazole)

Snippet

SUPPL AP for RECORLEV (LEVOKETOCONAZOLE)